by Sara M. Nolte | Dec 8, 2014
> In my previous toolbox articles (sphere formation and xenotransplantation), I’ve talked about assays that are pretty useful in determining the existence of cancer stem cell (CSC) populations based on function. What these assays cannot do is provide us with a way...
by Ben Paylor | Oct 24, 2014
> Just over one year ago, we launched the pilot phase of an animation project titled StemCellShorts here on Signals blog. Funded by a Stem Cell Network Public Outreach Award, the project was very much an experiment for us to see what would happen when you tasked a...
by Stacey Johnson | Sep 5, 2014
. Jordan Green, a biomedical engineer from Johns Hopkins, has a way with words. And toys. He’s like a Mister Rogers (American) or Mr. Dressup (Canadian) for adults. He has a complicated idea to convey, so borrowing from the best children’s entertainers around, he uses...
by Sara M. Nolte | Aug 19, 2014
> In previous posts, I have alluded to the fact that studying cancer in a dish (in vitro) is not optimal (here and here). Today, I give you the next essential tool in a cancer stem cell (CSC) researcher’s toolbox: xenotransplantation. Xenotransplantation is an...
by Mark Curtis | Aug 18, 2014
. Welcome to your Update from the Clinic for the month of July. The cancer stem cell companies were back in the news last month. OncoMed initiated its ALPINE clinical trial of Tarextumab for pancreatic cancer, while Stemline Therapeutics announced an investigational...
Comments